Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Palisade Bio Inc (NASDAQ: PALI) was $0.63 for the day, up 5.80% from the previous closing price of $0.6. In other words, the price has increased by $5.80 from its previous closing price. On the day, 0.5 million shares were traded. PALI stock price reached its highest trading level at $0.6357 during the session, while it also had its lowest trading level at $0.58.
Ratios:
Our analysis of PALI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.55 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 5916730 and an Enterprise Value of 700749.
Stock Price History:
The Beta on a monthly basis for PALI is 1.40, which has changed by -0.82102275 over the last 52 weeks, in comparison to a change of 0.1675967 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $4.32, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is -19.25%, while the 200-Day Moving Average is calculated to be -35.37%.
Shares Statistics:
PALI traded an average of 2.34M shares per day over the past three months and 1367740 shares per day over the past ten days. A total of 9.12M shares are outstanding, with a floating share count of 9.10M. Insiders hold about 0.24% of the company’s shares, while institutions hold 0.93% stake in the company. Shares short for PALI as of 1756425600 were 335095 with a Short Ratio of 0.14, compared to 1753920000 on 335788. Therefore, it implies a Short% of Shares Outstanding of 335095 and a Short% of Float of 3.6999999999999997.
Earnings Estimates
The current market rating for Palisade Bio Inc (PALI) reflects the collective analysis of 3.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.32 and low estimates of -$0.39.
Analysts are recommending an EPS of between -$1.55 and -$1.84 for the fiscal current year, implying an average EPS of -$1.72. EPS for the following year is -$1.24, with 3.0 analysts recommending between -$0.72 and -$1.77.
